Interestingly, none of the 16 ependymoma samples contained alterations in the EGFR-MAPK pathway; this is consistent with the idea that tumorigenesis is driven by entirely different mechanisms in different cell types within the developing central nervous system. Here, EGFR is linked to ependymoma.